News & Updates

Show Multimedia Only

Baricitinib plus phototherapy shows potential against extensive vitiligo

01 Feb 2025

Treatment with the combination of the small molecule Janus kinase 1/2 inhibitor baricitinib plus phototherapy may help reduce disease activity and induce repigmentation in adults with extensive and active nonsegmental vitiligo, according to the results of a phase II study.

Baricitinib plus phototherapy shows potential against extensive vitiligo

01 Feb 2025

Electrospun fibre patch to simplify psoriasis treatment

31 Jan 2025 by

A new patch that adheres to the skin and delivers two active ingredients holds promise in the treatment of psoriasis, reducing the need to apply topical medications to once a day and potentially improving adherence.

Electrospun fibre patch to simplify psoriasis treatment

31 Jan 2025

MAGIC database facilitates understanding of early-life gut microbiome dynamics

28 Jan 2025 by

The Metagenome-Assembled Genome Inventory for Children (MAGIC) database, which contains 20,172 global gut metagenomes from humans aged 0–7 years, characterizes the bacteriome and virome diversity of the global gut microbiome in early life.

MAGIC database facilitates understanding of early-life gut microbiome dynamics

28 Jan 2025

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?

23 Jan 2025 by

A large cohort study suggests that for patients with acne who received an isotretinoin treatment course, the cumulative dosage taken, rather than the daily dose, is a key factor for reducing the risk of relapse and treatment retrial.

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?

23 Jan 2025

Dupilumab-associated ocular surface disease less common in children, teens with AD

18 Jan 2025 by

The incidence of ocular surface disease associated with dupilumab treatment for moderate-to-severe atopic dermatitis is lower in children and adolescents than that described in adults, suggests a retrospective review at a tertiary paediatric hospital in Singapore

Dupilumab-associated ocular surface disease less common in children, teens with AD

18 Jan 2025

Photosensitivity status in atopic dermatitis may change over time

07 Jan 2025

Light sensitivity patterns vary in patients with atopic dermatitis (AD), reports a Scotland study, noting the significance of follow-up assessments because of potential shifts in disease spectrum over time.

Photosensitivity status in atopic dermatitis may change over time

07 Jan 2025

Original New Drug Application Approvals by US FDA (16-31 December 2024)

07 Jan 2025

New drug applications approved by US FDA as of 16-31 December 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 December 2024)

07 Jan 2025

Corticosteroid phobia tied to poor treatment adherence in chronic hand eczema

06 Jan 2025

Topical corticosteroid (TCS) phobia (TOPICOP) commonly exists among patients with chronic hand eczema (CHE) and often leads to poor treatment adherence, suggests a recent study.

Corticosteroid phobia tied to poor treatment adherence in chronic hand eczema

06 Jan 2025

Anti–IL-23 monoclonal antibody shows promise in plaque psoriasis

22 Dec 2024

QX004N, a humanized IgG1λ monoclonal antibody targeting IL-23, is superior to placebo in the treatment of patients with moderate to severe plaque psoriasis, according to a phase I trial.

Anti–IL-23 monoclonal antibody shows promise in plaque psoriasis

22 Dec 2024

Original New Drug Application Approvals by US FDA (1-15 December 2024)

20 Dec 2024

New drug applications approved by US FDA as of 1-15 December 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 December 2024)

20 Dec 2024

News & Updates

Showing Dermatology articles

Showing

Specialty:

Baricitinib plus phototherapy shows potential against extensive vitiligo

Baricitinib plus phototherapy shows potential against extensive vitiligo

Electrospun fibre patch to simplify psoriasis treatment

Electrospun fibre patch to simplify psoriasis treatment

MAGIC database facilitates understanding of early-life gut microbiome dynamics

MAGIC database facilitates understanding of early-life gut microbiome dynamics

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?

Isotretinoin for acne: Higher total dose exposure, lower relapse risk?

Dupilumab-associated ocular surface disease less common in children, teens with AD

Dupilumab-associated ocular surface disease less common in children, teens with AD

Photosensitivity status in atopic dermatitis may change over time

Photosensitivity status in atopic dermatitis may change over time

Original New Drug Application Approvals by US FDA (16-31 December 2024)

Original New Drug Application Approvals by US FDA (16-31 December 2024)

Corticosteroid phobia tied to poor treatment adherence in chronic hand eczema

Corticosteroid phobia tied to poor treatment adherence in chronic hand eczema

Anti–IL-23 monoclonal antibody shows promise in plaque psoriasis

Anti–IL-23 monoclonal antibody shows promise in plaque psoriasis

Original New Drug Application Approvals by US FDA (1-15 December 2024)

Original New Drug Application Approvals by US FDA (1-15 December 2024)